
Loading, please wait...

Loading, please wait...

Large registry data provide a useful real-world complement to randomized trials of femtosecond laser-assisted cataract surgery (FLACS). A multicenter study from the European Registry of Quality Outcomes for Cataract and Refractive Surgery matched 2,814 femtosecond-assisted cases with 4,987 conventional phacoemulsification cases across multiple countries. Visual acuity, refractive prediction error, and postoperative complications were compared. FLACS did not demonstrate better postoperative corrected distance visual acuity or refractive accuracy. The proportion of eyes within ±0.50 D of target was similar, while postoperative complications were lower in the conventional phaco group in this registry analysis. The practical message for cataract surgeons is that technology selection should not be driven solely by the promise of greater precision. Modern conventional phaco already provides excellent outcomes when performed with disciplined biometry, capsulorhexis, fluidics, and IOL positioning. FLACS may remain useful in selected cases where automated laser-assisted steps offer a procedural benefit, but the registry findings argue against assuming a universal outcome advantage. In patient discussions, clinicians can frame FLACS as an alternative surgical platform rather than an inherently superior replacement for standard phacoemulsification.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Large registry data provide a useful real-world complement to randomized trials of femtosecond laser-assisted cataract surgery (FLACS). A multicenter study from the European Registry of Quality Outcomes for Cataract and Refractive Surgery matched 2,814 femtosecond-assisted cases with 4,987 conventional phacoemulsification cases across multiple countries. Visual acuity, refractive prediction error, and postoperative complications were compared. FLACS did not demonstrate better postoperative corrected distance visual acuity or refractive accuracy. The proportion of eyes within ±0.50 D of target was similar, while postoperative complications were lower in the conventional phaco group in this registry analysis. The practical message for cataract surgeons is that technology selection should not be driven solely by the promise of greater precision. Modern conventional phaco already provides excellent outcomes when performed with disciplined biometry, capsulorhexis, fluidics, and IOL positioning. FLACS may remain useful in selected cases where automated laser-assisted steps offer a procedural benefit, but the registry findings argue against assuming a universal outcome advantage. In patient discussions, clinicians can frame FLACS as an alternative surgical platform rather than an inherently superior replacement for standard phacoemulsification.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back